Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000024

Chief Medical Officer sold 416 shares at $31.33 ($13,033)

  • Chief Medical Officer acquired 416 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-04-17 Option exercise 10b5-1 +416 $15.44 $6,423 70,208 D
Rodman David Malcom Chief Medical Officer 2026-04-17 Sale 10b5-1 −416 $31.33 $13,033 69,792 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-04-17 Option exercise · Stock Option 10b5-1 −416 4,584 D
Open-market sales · 416 sh · avg $31.33 · $13,033
Loading xslF345X06/wk-form4_1776812373.xml…